Quote Biotech & medicine· Oct 20, 2026

Updated provider agreement was interpreted in unintended ways

We sent out an updated Provider Agreement yesterday, and a lot of you wrote back, understandably. It was very reasonably interpreted in ways we never intended. This isn’t our standard, and I take responsibility.

email to Headway providers

Andrew AdamsHeadway · CEO

Where it comes from

statnews.com · 2026-10-20

Also from this article

Dror Walter — Science views explain partisan vaccine gap for MMR and flu Dror Walter — Covid-19 vaccine partisanship not explained by views of…

On the same topic: Biotech & medicine

Vas Narasimhan Novartis

Novartis seeks accelerated FDA approval for pelabresib

“Novartis now expects to speak with the FDA about a potential accelerated approval of pelabresib before the end of the year, CEO Vas Narasimhan told investors on a call Tuesday.”

Biotech & medicine·yesterday·fiercepharma.com

Elizabeth Mitchell Purchaser Business Group on Health

Health industry consolidation has worsened prices and access

“The industry has gotten more consolidated. Prices are higher than ever. Access is worse than ever.”

Biotech & medicine·yesterday·statnews.com

Julian Zelizer Princeton University

Rising health costs are unsustainable for individuals and businesses

“The rising costs are unsustainable for individuals, for businesses, and for the country. What kind of intervention is a different question.”

Biotech & medicine·yesterday·statnews.com